Concepedia

Author

Laurence Slama

Sorbonne Université

Also Known As

Barbara Gasse, G. Pialoux, JL Esnault, L Ben Slama, L Slama, L. Slama, Laurence Slama, TH Nguyen

38

Publications

1K

Citations

19

H-Index

36

Concepts

All Affiliations

Sorbonne UniversitéInsermHôpital TenonAssistance Publique – Hôpitaux de ParisPitié-Salpêtrière Hospital
LS

About

Laurence Slama is an author at Sorbonne Université specializing in medicine, immunology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

332

2

Immunology

5

5

178

3

Cell Biology

1

1

68

4

Clinical Immunology

1

1

68

5

Epidemiology

1

1

23

Laurence Slama

×

16

Publications

739

Citations

15

H-Index

YearCitations

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

Jean‐Michel Molina, Béatrice Berçot, Lambert Assoumou,

The Lancet Infectious Diseases

2024

129

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

François Raffi, Chloe Orkin, Amanda Clarke,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2017

83

Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters

Laurence Slama, Frank J. Palella, Alison G. Abraham,

Journal of Antimicrobial Chemotherapy

2014

70

HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term

Benoît Vingert, Daniela Benati, Olivier Lambotte,

Journal of Virology

2012

68

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus

Aurélie Schnuriger, Stéphanie Dominguez, Marguerite Guiguet,

AIDS

2009

66

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

M.A. Valantin, Sidonie Lambert-Niclot, Philippe Flandre,

Journal of Antimicrobial Chemotherapy

2011

66

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study

Gilles Pialoux, Hakim Hocini, Sophie Pérusat,

Vaccine

2007

36

HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization

Iván Landires, Florence Bugault, Olivier Lambotte,

AIDS

2011

35

Serologic Response to Hepatitis B Vaccination in HIV‐Infected Patients with Isolated Positivity for Antibodies to Hepatitis B Core Antigen

Catherine Chakvetadze, Firouzé Bani‐Sadr, Catherine Le Pendeven,

Clinical Infectious Diseases

2010

33

Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study

Gilles Pialoux, Romina Quercia, Hanne Gahéry,

Clinical and Vaccine Immunology

2008

27

Page 1